Breast Cancer HER2 Test For Herceptin Candidates Approved By FDA
The US Food and Drug Administration (FDA) announced on Tuesday that it had approved a new test that measures the strength of HER2 gene amplification in breast cancer patients so that decisions can be made about whether they should be given the cancer drug Herceptin (trastuzumab).
More... |
All times are GMT -7. The time now is 02:22 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021